SupplementScore.org

Vitamin D for autistic children: what the RCTs actually show

6 min read · By the · Updated · How we research
Bottom Line

Autistic children do tend to have lower vitamin D levels than their peers, but the controlled-trial picture is narrower than either enthusiasts or skeptics suggest: correcting a real deficiency is reasonable, yet vitamin D does not “treat” autism. A 2023 review of eight trials (266 children) found a small improvement in stereotypical-behavior scores and no clear gain on the other core-symptom scales. A separate 20-week trial of 2,000 IU a day did not change its primary behavior score. High-dose “autism cure” protocols risk hypercalcemia and can pull families away from early intervention, speech, and behavioural therapy. The sensible course is to correct a documented deficiency and treat anything beyond that as unproven.

Cross-sectional studies have consistently found that children with autism spectrum disorder (ASD) have lower mean 25-hydroxyvitamin D levels than neurotypical peers, which has fueled both clinical trials and an unfortunate amount of speculation about vitamin D as a treatment. The 2026 picture from controlled trials is narrower than either the enthusiasts or the skeptics frame: vitamin D supplementation in deficient autistic children corrects deficiency and produces small effects on some behaviour scales, but does not "treat" autism. The sections below trace the observational pattern, the RCTs in diagnosed children, and what the evidence does and does not support.

The observational pattern

Whether this represents causal contribution, reverse causation (restricted diet, indoor preference, sun avoidance), or a shared confounder is debated. The 2019 Mendelian randomization study by Vinkhuyzen and colleagues found a small association between maternal pregnancy 25(OH)D and offspring autism traits, supporting at least partial causal contribution from gestational status.1

What the RCTs in already-diagnosed children show

The 2019 RCT by Mazahery and colleagues in 117 children aged 2.5–8 years using 2,000 IU/day vitamin D3 versus placebo did not show significant effects on the Social Responsiveness Scale.2 Kerley and colleagues in Dublin randomized 42 children to 2,000 IU of vitamin D3 or placebo for 20 weeks. Thirty-eight finished. Vitamin D raised blood levels but did not change the primary stereotypic-behavior score. The authors called the other effects limited and inconsistent.3

What a 2023 review found

A 2023 systematic review included eight randomized trials and 266 children, and pooled six of the trials. Vitamin D improved stereotypical-behavior scores (mean difference −1.39). Scores on the other core-symptom scales did not show a clear difference. The authors said larger trials are still needed.5 Those effects are much smaller than the changes expected from behavioural therapies.

What it does not do

Vitamin D does not "cure" or substantively reduce core ASD symptoms (social communication deficits, repetitive behaviours). It does not eliminate the need for early intervention, speech and occupational therapy, or applied behavioural analysis. Promoting high-dose vitamin D as autism treatment — particularly the megadose protocols sometimes seen in alternative-medicine clinics — risks both diverting families from effective interventions and producing iatrogenic hypercalcaemia. The Endocrine Society's 2024 pediatric vitamin D guideline reiterates that supplementation in children should target 25(OH)D adequacy (>20 ng/mL on US thresholds) and not be used as a pharmacologic intervention for behavioural conditions.4

Practical pediatric dosing

For pediatric patients with documented deficiency (25(OH)D <20 ng/mL): 1,000-2,000 IU/day vitamin D3 for 8-12 weeks, then maintenance 400-600 IU/day, with rechecking of serum levels. The Institute of Medicine UL is 4,000 IU/day for children aged 9-18, 3,000 IU/day for ages 4-8, and 2,500 IU/day for ages 1-3. Megadose protocols (>5,000 IU/day chronically) require pediatric endocrinology oversight and serum calcium monitoring. Calcium and parathyroid hormone should be checked at baseline before initiating high doses. Hypercalcemia from over-supplementation is reported in case series.

The honest framing for families

Correcting vitamin D deficiency in an autistic child is reasonable and aligned with general pediatric care, especially in children with restricted diets or limited sun exposure. The behaviour-scale changes in the trials above are small and do not substitute for evidence-based behavioural and educational interventions. Families should be wary of clinics promoting megadose protocols or framing vitamin D as an autism cure.

Sources

  1. Vinkhuyzen AAE, Eyles DW, Burne THJ, et al. "Gestational vitamin D deficiency and autism-related traits: the Generation R Study." Mol Psychiatry, 2018;23(2):240-246. PMID: 27895322. DOI: 10.1038/mp.2016.213
  2. Mazahery H, Conlon CA, Beck KL, et al. "A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder." J Steroid Biochem Mol Biol, 2019;187:9-16. PMID: 30744880. DOI: 10.1016/j.jsbmb.2018.10.017
  3. Kerley CP, Power C, Gallagher L, Coghlan D. "Lack of effect of vitamin D3 supplementation in autism: a 20-week, placebo-controlled RCT." Arch Dis Child, 2017;102(11):1030-1036. PMID: 28626020. DOI: 10.1136/archdischild-2017-312783
  4. Demay MB, Pittas AG, Bikle DD, et al. "Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab, 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290
  5. Zhang M, Wu Y, Lu Z, et al. "Effects of Vitamin D Supplementation on Children with Autism Spectrum Disorder: A Systematic Review and Meta-analysis." Clin Psychopharmacol Neurosci, 2023;21(2):240-251. PMID: 37119216. DOI: 10.9758/cpn.2023.21.2.240